Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

4D MOLECULAR THERAPEUTICS, INC.

(FDMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about 4D MOLECULAR THERAPEUTICS, INC.
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of ..
PU
08/124D MOLECULAR THERAPEUTICS : Earnings Flash (FDMT) 4D MOLECULAR THERAPEUTICS Repo..
MT
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of ..
AQ
08/124D Molecular Therapeutics, Inc. Announces Unaudited Earnings Results for the ..
CI
08/124D Molecular Therapeutics, Inc. Appoints Nadine Greiner as Chief Human Resour..
CI
06/254D Molecular Therapeutics, Inc. Announces Rare Disease Ophthalmology Product ..
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Growth Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Growth In..
CI
06/254D-110 : Initial clinical safety data at both of the two dose levels in the Phas..
PU
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Value Ind..
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Value Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Index
CI
06/244D MOLECULAR THERAPEUTICS : Says Roche Stops Trial, Cancels Licensing Deal for E..
MT
06/244D Molecular Shares Hit 52-Week Low After Roche Ends Collaboration Agreement
DJ
06/244D Molecular Therapeutics Gets Termination Notice From Roche
DJ
06/244D MOLECULAR THERAPEUTICS : Announces Rare Disease Ophthalmology Product Candida..
AQ
06/214D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to S&P Global BMI Index
CI
06/09Certain Warrants of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up ..
CI
06/0916,833,726 Common Stock of 4D Molecular Therapeutics, Inc. are subject to a L..
CI
06/09Certain Stock Options of 4D Molecular Therapeutics, Inc. are subject to a Loc..
CI
06/08CHOROIDEREMIA PIPELINE : Emerging Therapies and Key pharma players involved by D..
AQ
06/074D MOLECULAR THERAPEUTICS : Appoints Carolyne Zimmermann as Chief Business Offic..
AQ
06/074D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Offi..
CI
06/034D MOLECULAR THERAPEUTICS : to Participate in Goldman Sachs 42nd Annual Global H..
AQ
05/134D Molecular Therapeutics Reports Financial Results for the First Quarter of ..
GL
05/134D Molecular Therapeutics, Inc. Announces Unaudited Earnings Results for the ..
CI
05/124D Molecular Therapeutics Presents Non-Human Primate Preclinical Data at ASGC..
GL
05/124D Molecular Therapeutics Presents Non-Human Primate Preclinical Data at ASGC..
CI
05/044D Molecular Therapeutics Announces Collaboration on Leading Machine Learning..
GL
04/304D Molecular Therapeutics to Participate in BofA Securities 2021 Virtual Heal..
GL
04/274D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT a..
GL
04/274D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT a..
CI
04/06Mr. William Burkoth to Not Stand for Re-Election as Director of 4D Molecular ..
CI
03/31JOHN MARTIN : John Martin, Who Built Gilead Into HIV, Hepatitis Powerhouse, Dies
DJ
03/264D MOLECULAR THERAPEUTICS : Posts Narrower Net Loss, Higher Revenue in 2020
MT
03/254D Molecular Therapeutics, Inc. Announces Changes to Its Board
CI
03/254D Molecular Therapeutics Reports Financial Results for the Year Ended Decemb..
GL
03/254D Molecular Therapeutics Provides Operational Highlights
CI
03/254D Molecular Therapeutics, Inc. Announces Consolidated Earnings Results for t..
CI
03/214D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to S&P TMI Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000 Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Small Cap Comp Val..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Growth Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Value Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Small Cap Comp Gro..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Growth Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000 Value Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Value Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Value Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Value-Dynamic..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Growth-Dynami..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Value-Dynamic..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Dynamic Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000 Growth Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2000 Growth-Dynami..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Small Cap Complete..
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 2500 Dynamic Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Index
CI
03/184D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Growth Index
CI
03/094D MOLECULAR THERAPEUTICS : Doses First Patient in Phase 1/2 Trial of 4D-310 to ..
MT
03/094D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical..
GL
03/094D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical..
CI
01/054D MOLECULAR THERAPEUTICS : BofA Securities Starts 4D Molecular Therapeutics at ..
MT
01/054D MOLECULAR THERAPEUTICS : Evercore ISI Starts 4D Molecular Therapeutics at Out..
MT
01/054D MOLECULAR THERAPEUTICS : Goldman Sachs Starts 4D Molecular Therapeutics at Ne..
MT
20204D Molecular Therapeutics Announces Closing of Initial Public Offering and Fu..
GL
20204D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to NASDAQ Composite Index
CI
20204D MOLECULAR THERAPEUTICS : Prices $193.2 Million IPO
MT
20204D Molecular Therapeutics, Inc. has completed an IPO in the amount of $193.2 ..
CI
20204D Molecular Therapeutics, Inc Announces Executive Appointments
CI
20204D Molecular Therapeutics, LLC Announces Board Appointments
CI
20204D Molecular Therapeutics, Inc. has filed an IPO in the amount of $75 million..
CI
1  2Next